Schedule 13G ownership disclosure

ACTINIUM PHARMACEUTICALS INC

Common Stock · CUSIP: 00507W206

Event date: 2025-06-30

Filing-level shares
462,969
Percent of class
1.5%
  • BlackRock, Inc.

    Shares: 462,969 · Class: 1.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-002468
Form type
SCHEDULE 13G/A
Filer
Actinium Pharmaceuticals, Inc.
CIK
CIK 1388320
Filed
Jul 16, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub